Egypt Diabetes Devices Market Size, Share, Growth, Trends, and Industry Analysis: By Product Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices, Artificial Pancreas Systems), By Device Type (Self-Monitoring, Diagnostic Devices), By Delivery Type (Pumps, Insulin Pens, Syringes, Injectors, Disposable Pen, Jet Injectors), By Distribution Channel (Hospitals, Clinics, Retail Sales, Online Pharmacies) and Country

Egypt Diabetes Devices Market size was valued at US$ 423.9 million in 2023 and is projected to reach a value of US$ 550.4 million by 2030, growing at a CAGR of 3.8% from 2024-2030.

The Egypt Diabetes Devices market is the market for medical devices used to treat and manage diabetes. Diabetes devices refer to various medical technologies designed to help individuals manage their diabetes effectively, these devices assist patients in monitoring their blood sugar levels and administering insulin without needing manual injections, making diabetes management easier and less invasive. the key drivers of the market are increasing prevalence of diabetes, rising awareness of diabetes treatment and management. However, the key restraints of the market are high cost of devices, lack of awareness about diabetes management and the benefits of using advanced devices. Additionally, the opportunities of the market are innovations in diabetes care, such as continuous glucose monitoring systems (CGMS) and smart insulin pens offer more efficient and user-friendly solutions, integration with digital health. The key trends of the market are increased adoption of insulin delivery devices, increased focus on paediatric diabetes management, rising demand for compact and portable devices.

Key Players

The leading companies highlighted in the market report include such as such as Abbott Diabetes Care, Medtronic PLC, Roche Diabetes Care, Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A, Omnipod, and others. Also, a comprehensive analysis of industry verticals and market participants that provides a clear overview of the competitive landscape in relation to the sectors served by the company’s products and services, market share, service offerings, financial reports, significant developments, market strategy, competitive position, and geographic reach.

Key Takeaways

• The growth rate of the market was estimated to grow at a compound annual growth rate (CAGR) of approximately 7.45% from 2024 to 2030.
• Based on product type, the blood glucose monitoring devices segment is dominant in 2023.
• Based on device type, the self-monitoring device segment is dominating the market.
• Based on delivery type, the insulin pens has captured the highest market share in 2023.   
• Based on distribution channel, the retain sales has expected to dominate the market in coming forecast years.

Facts & Figures

• In 2019, Abbott and Dexcom have introduced advanced continuous glucose monitoring devices, such as the Freestyle Libre and Dexcom G6, into the Egyptian market. These devices have gained popularity due to their ease of use and ability to provide real-time glucose monitoring without the need for frequent finger-pricking.
• In 2021, Novo Nordisk partnered with the Ministry of Health and Population in Egypt to improve diabetes care, focusing on early detection, patient education, and the adoption of advanced diabetes devices. Such collaborations have accelerated the deployment of innovative products and improved access to diabetes management tools.

Key Developments

In May 2021, Medtronic plc introduced that the corporation had acknowledged European adoption for 2 diabetes management devices, first in pen, an associated insulin pen aimed at customers demanding day-to-day injections. The second is Guardian 4 sensor, planned to be used either as a standalone constant glucose monitor or within a pen, and together are CE noticeable.

Egypt Diabetes Devices Market Segmentation

By Product Type: Among the all the product types, the blood glucose monitoring devices is dominating the market. This dominance is driven by the increasing prevalence of diabetes worldwide and the critical need for regular blood glucose monitoring to manage the condition effectively. Continuous glucose monitoring (CGM) systems and self-monitoring blood glucose (SMBG) devices are particularly popular, as they provide real-time data and help patients maintain better control over their blood sugar levels.

By Device Type: The self-monitoring segment is most widely used in the market as it allows individuals to easily and frequently monitor their blood glucose levels at home. Self-monitoring blood glucose (SMBG) devices, such as glucometers and test strips, provide real-time data that helps patients manage their diabetes more effectively. This segment is particularly popular among people with type 2 diabetes, who need to regularly check their blood sugar levels to adjust their diet, exercise, and medication.

By Delivery Type: Among all the delivery types, insulin pens are dominating the market due to several factors like they are more convenient and easier to use compared to traditional syringes and vials, they are compact and portable allowing patients to administer insulin discreetly and on the go. These are the factors which are driving the growth of market.